DLA Piper advises on Sperco Ukraine investment

DLA Piper Ukraine has advised Europe Virgin Fund (EVF), a private equity fund, sponsored by Dragon Capital in set up of a joint venture with Ucrafarma SA.

The parties invested into Lux PHARMA Participations SA, a Luxembourg-based holding company, with Ucrafarma SA transferring various pharmaceutical assets including its 95 per cent stake in Sperco Ukraine LLC, one of the top 10 pharmaceutical manufacturers of Ukraine, and EVF providing capital for further development

DLA Piper provided full legal support to the transaction, including legal due diligence of Ukrainian and Spanish assets, drafting and negotiating transactional documents governed by English, Ukrainian and Spanish law, support of closing of the deal.

The DLA Piper team was led by legal director Illya Muchnyk under the general supervision of managing partner Margarita Karpenko. The significant input was provided by finance and projects associates Dmytro Pshenychnyuk, Maxim Andrianov, Dmytro Lapa and real estate associates — Oleg Matiusha.

  • Print

Briefings from DLA Piper

View more briefings from DLA Piper

Analysis from The Lawyer

View more analysis from The Lawyer

Overview

3 Noble Street
London
EC2V 7EE
UK
http://www.dlapiper.com

Turnover (£m): 1,539.00
No. of lawyers: 4,374(UK 200)
Jurisdiction: Global
No. of offices: Over 75
No. of qualified lawyers: 625 (International 50)

Jobs